Drug Report History
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.
Version v10-EN | Version v10-EN | |
---|---|---|
Language | English | English |
Date Updated | 2019-03-15 | 2019-03-15 |
Drug Identification Number | 02431130 | 02431130 |
Brand name | VINORELBINE INJECTION, USP | VINORELBINE INJECTION, USP |
Common or Proper name | 10 mg/ml Vinorelbine (as vinorelbine tartrate) | 10 mg/ml Vinorelbine (as vinorelbine tartrate) |
Company Name | GENERIC MEDICAL PARTNERS INC | GENERIC MEDICAL PARTNERS INC |
Ingredients | VINORELBINE | VINORELBINE |
Strength(s) | 10MG | 10MG |
Dosage form(s) | SOLUTION | SOLUTION |
Route of administration | INTRAVENOUS | INTRAVENOUS |
Packaging size | 5 ML IN CLEAR GLASS VIAL | 5 ML IN CLEAR GLASS VIAL |
ATC code | L01CA | L01CA |
ATC description | PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS | PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS |
Reason for shortage | Delay in shipping of the drug. | Delay in shipping of the drug. |
Anticipated start date | 2019-02-25 | 2019-02-25 |
Actual start date | ||
Estimated end date | 2019-03-14 | 2019-03-14 |
Actual end date | 2019-03-14 | 2019-03-14 |
Shortage status | Resolved | Resolved |
Tier 3 Status | No | No |
Company comments | The latest batch of Vinorelbine 10mg/ml 5 ml vials has cleared QA and have been released. Regular supply of both Vinorelbine 10mg/ml 5 ml and 1 ml vials has now been re-established. The allocation process set in place for 5 ml vials with contracted accounts has been removed. GMP did not have a complete shortage during the allocation process. There is already an existing supply of Vinorelbine 10mg/ml 1 ml vials to meet usual national requirements. | The latest batch of Vinorelbine 10mg/ml 5 ml vials has cleared QA and have been released. Regular supply of both Vinorelbine 10mg/ml 5 ml and 1 ml vials has now been re-established. The allocation process set in place for 5 ml vials with contracted accounts has been removed. GMP did not have a complete shortage during the allocation process. There is already an existing supply of Vinorelbine 10mg/ml 1 ml vials to meet usual national requirements. |
Health Canada comments |